Treatment of vitamin D deficiency is an effective method in the elimination of asymptomatic bacterial vaginosis: A placebo-controlled randomized clinical trial

被引:24
|
作者
Taheri, Mahshid [1 ]
Baheiraei, Azam [2 ]
Foroushani, Abbas Rahimi [3 ]
Nikmanesh, Bahram [4 ]
Modarres, Maryam [1 ]
机构
[1] Univ Tehran Med Sci, Dept Midwifery, Sch Nursing & Midwifery, Tehran, Iran
[2] Univ Tehran Med Sci, Reprod Hlth Dept, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Parasitol & Mycol, Tehran, Iran
关键词
bacterial vaginosis; reproductive age women; vaginal infection; vitamin D; PREGNANT-WOMEN; HIGH PREVALENCE; VAGINAL FLORA; 1ST TRIMESTER; RISK-FACTORS; 25-HYDROXYVITAMIN-D; HEALTH;
D O I
10.4103/0971-5916.160707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: Bacterial vaginosis (BV) is the most prevalent vaginal infection in women of reproductive age group which has been found to be associated with vitamin D deficiency. The purpose of this study was to investigate the effectiveness of the administration of 2000 IU/day edible vitamin D for 15 wk to eliminate asymptomatic BV among reproductive age women with vitamin D deficiency. Methods: A total of 208 women with asymptomatic BV, who were found to be eligible after interviews and laboratory tests, were randomly assigned to a control group (n=106) or an intervention group (n=105). They used vitamin D drops daily for 105 days. Vaginal and blood samples were taken before and after the second intervention using identical methods (Nugent score for BV diagnosis, serum 25-hydroxyvitamin D for vitamin D determination). Results: The cure rate of asymptomatic BV was 63.5 per cent in the intervention and 19.2 per cent in the control group (P<.001). The results showed that being unmarried (P=0.02), being passive smoker (P<0.001), and being in the luteal phase of a menstrual cycle during sampling (P=0.01) were significantly associated with post-intervention BV positive results. After these elements were controlled, the odds of BV positive results in the control group was 10.8 times more than in the intervention group (P<0.001). Interpretation & conclusions: Among women in reproductive age group with vitamin D deficiency, the administration of 2000 IU/day edible vitamin D was effective in eliminating asymptomatic BV. This treatment could be useful in preventing the symptoms and side effects of BV.
引用
收藏
页码:799 / 806
页数:8
相关论文
共 50 条
  • [1] Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized Placebo-Controlled Trial
    Mancuso, Abigail C.
    Widdice, Lea E.
    Hughes, Brenna L.
    Schlievert, Patrick
    Swamy, Geeta K.
    Stockdale, Colleen K.
    Bernstein, David I.
    Winokur, Patricia L.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2020, 24 (03) : 277 - 283
  • [2] Treatment of Male Sexual Partners of Women With Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled Trial
    Schwebke, Jane R.
    Lensing, Shelly Y.
    Lee, Jeannette
    Muzny, Christina A.
    Pontius, Angela
    Woznicki, Nicole
    Aguin, Tina
    Sobel, Jack D.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : E672 - E679
  • [3] Effects of vitamin D on patients with fibromyalgia syndrome: A randomized placebo-controlled trial
    Wepner, Florian
    Scheuer, Raphael
    Schuetz-Wieser, Birgit
    Machacek, Peter
    Pieler-Bruha, Elisabeth
    Cross, Heide S.
    Hahne, Julia
    Friedrich, Martin
    PAIN, 2014, 155 (02) : 261 - 268
  • [4] A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis
    Turner, Abigail Norris
    Reese, Patricia Carr
    Fields, Karen S.
    Anderson, Julie
    Ervin, Melissa
    Davis, John A.
    Fichorova, Raina N.
    Roberts, Mysheika Williams
    Klebanoff, Mark A.
    Jackson, Rebecca D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 211 (05)
  • [5] Vitamin D supplementation to persistent carriers of MRSA—a randomized and placebo-controlled clinical trial
    Linda Björkhem-Bergman
    Catharina Missailidis
    John Karlsson-Valik
    Ann Tammelin
    Lena Ekström
    Matteo Bottai
    Ulf Hammar
    Gudrun Lindh
    Peter Bergman
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1735 - 1744
  • [6] Treatment for Symptomatic Bacterial Vaginosis: A Randomized Controlled Trial
    Tariq, Nabia
    Basharat, Ayesha
    Khan, Danish Hassan
    Fahim, Ammad
    Khan, Mohammad Hisham
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2017, 27 (11): : 686 - 689
  • [7] Vitamin D supplementation and fracture incidence in elderly persons - A randomized, placebo-controlled clinical trial
    Lips, P
    Graafmans, WC
    Ooms, ME
    Bezemer, PD
    Bouter, LM
    ANNALS OF INTERNAL MEDICINE, 1996, 124 (04) : 400 - +
  • [8] A multicenter, double-blind, randomized, placebo-controlled study of rifaximin for the treatment of bacterial vaginosis
    Donders, Gilbert G. G.
    Guaschino, Secondo
    Peters, Klaus
    Tacchi, Raffaella
    Lauro, Vittoria
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2013, 120 (02) : 131 - 136
  • [9] Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled clinical trial
    Petersen, Elko E.
    Genet, Margherita
    Caserini, Maurizio
    Palmieri, Renata
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2011, 61 (04): : 260 - 265
  • [10] Vitamin D supplementation to persistent carriers of MRSA-a randomized and placebo-controlled clinical trial
    Bjorkhem-Bergman, Linda
    Missailidis, Catharina
    Karlsson-Valik, John
    Tammelin, Ann
    Ekstrom, Lena
    Bottai, Matteo
    Hammar, Ulf
    Lindh, Gudrun
    Bergman, Peter
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (09) : 1735 - 1744